Navigation Links
New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study

MIAMI, Oct. 16 /PRNewswire/ -- Roger K. Khouri, M.D. a noted Plastic and Reconstructive Surgeon, is presently leading a team of surgeons in a clinical trial performing a minimally invasive breast reconstruction technique utilizing the Brava external expansion system and liposuctioned micro-fat grafts primarily on women who have had a mastectomy or lumpectomy, with or without radiation therapy.

Typically, breast reconstruction procedures involve major, "open" surgery that requires extensive recovery time. With this new minimally-invasive outpatient breast reconstruction technique, the chest wall is first expanded by using the Brava System and is followed by the re-injection of small micro- grafts that are harvested, through a liposuction procedure, from the patients own body (autologous grafts). These micro-fat grafts are most often harvested from the patient's thighs, buttocks and stomach. A key element to the success of this procedure, an average 90% graft survival rate, is the preparation of the recipient breast site with the expansion device (Brava) enabling greater volumes of fat to be transferred, and its post operative use to stabilize the graft ensuring its survival. Slowly, after undergoing a few procedures, the breasts are reconstructed. Following each treatment, patients are ambulatory and recovery time is minimal.

The study is actively recruiting the following types of participants: post lumpectomy patients, post mastectomy patients or those post breast biopsy, that were left with a filling defect, who do not have breast implants. Further information about the clinical trial and enrollment criteria may be found at

About Dr. Khouri

Roger K. Khouri, M.D., is a world renowned plastic and reconstructive surgeon practicing in Miami, FL and the inventor of the Brava System. Prior to co-founding Brava, LLC, Dr. Khouri held professional and fellowship positions at Brown, Harvard, New York and Washington Universities.

About Brava, LLC

Brava, LLC, founded in 1999, is a medical device manufacturer. Products include the Brava Breast Enhancement System. Brava, LLC headquarters are located at 14221 S.W. 142nd Street, Miami, FL 33186

Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Non-Invasive Diagnostic Tests for Celiac Disease
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
7. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
11. New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):